SecBot SecBot

MDXH

MDxHealth SA
Nasdaq· Services-Medical Laboratories· Inc. C9· CIK 0001872529 Healthcare & Medical Devices
$0.1867 −0.01 (−4.26%)
Oct 27 4:00 PM ET · prev $0.1950
Market cap
$17.6M
Nano cap
Consensus
Buy
75% Buy or better · 12 analysts
Median target
$1.00
+436% · range $0.5000–1.00
1 year
−96.1%
from $4.79 · Oct 27
30 days
−65.9%
from $0.5480
52-week range
$0.1830–5.00
−96% from high · low Oct 19
Avg volume 20D
1.73M
Oct 16 spike 17.31M
Short interest
🔒 Subscribers only
Insider net
+$1000.0K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read BEARISH 7 reports · 90 days
Balance 6 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 5/7

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $1000.0K at an average $0.4540. No open-market sales. Price is 59% below their cost.

  • InstitutionsMIXED

    Q2 2026: 4 added (0 new), 4 trimmed or exited.

  • AnalystsBULLISH

    9 of 12 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.162 → −$0.092 over 90 days. 5 up, 0 down in 30 days.

  • TrendDOWNTREND

    68% below its 50-day average. New closing low $0.1830 on Oct 23.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 18.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCDOUBLED509,674$209.3K
MILLENNIUM MANAGEMENT LLCTRIM228,510$93.8K
HRT FINANCIAL LPDOUBLED184,477$75.0K
BlackRock, Inc.ADD147,063$60.4K
Lido Advisors, LLCADD20,253$8.3K
MORGAN STANLEYNEAR_EXIT764$313.00
BARCLAYS PLCNEAR_EXIT16$7.00
UBS Group AGNEAR_EXIT3$1.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 75% rate it Buy or better
Strong Buy3Buy6Hold3Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +436%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 19, 2026BTIG
DOWNGRADE
DOWNGRADENeutral
Aug 21, 2026BTIG
MAINTAIN
MAINTAINBuy
Aug 14, 2026Lake Street
MAINTAIN
MAINTAINBuy
May 14, 2026Lake Street
MAINTAIN
MAINTAINBuy
May 14, 2026TD Cowen
MAINTAIN
MAINTAINBuy
May 14, 2026BTIG
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$1000.0K
bought · 1 insider
$0
sold · 0 insiders
−58.9%
vs their $0.4540 cost
DateInsiderTypeValue
Aug 13, 2026
MVM Partners, LLC
Director
BUY$1000.0K
Jun 1, 2026
McGarrity Michael
Chief Executive Officer
AWARD329,800 sh
Jun 1, 2026
Sollee Joseph
See Remarks
AWARD83,000 sh
Jun 1, 2026
Bellano John
Chief Commercial Officer
AWARD116,000 sh
Jun 1, 2026
Windels Hilde
Director
AWARD10,000 sh
Jun 1, 2026
Holder Michael
Director
AWARD10,000 sh
Jun 1, 2026
Siegel Sanford Jay
Director
AWARD10,000 sh
Jun 1, 2026
Hoffman Koen
Director
AWARD10,000 sh

Earnings setup

Estimates
−$0.09
EPS estimate, this quarter
+43%
estimate change, 90 days
5↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.09-$0.11–-$0.06+0.0%$25.2M
Next Q-$0.08-$0.10–-$0.05+0.0%$26.8M
Current FY-$0.46-$0.46–-$0.46+0.0%$97.7M
Next FY-$0.38-$0.38–-$0.38+0.0%$110.7M
Reddit mentions per day, 14 days
Recent posts
All social signals and their track records

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Aug 14, 2026Volatility PauseResumed
Aug 14, 2026Volatility PauseResumed
Aug 14, 2026Volatility PauseResumed
Aug 14, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
MDxHealth announced preliminary Q3 2026 revenue of $22.7M (flat YoY), suspended its full-year 2026 revenue guidance of…
6-K — Impact 6/10
Oct 15, 2026 SEC
Bleichroeder LP filed an amended Schedule 13D for MDxHealth SA, disclosing beneficial ownership of 30,571,922 ordinary…
SC 13D/A — Impact 6/10
Oct 15, 2026 SEC
mdxhealth pre-announced Q3 2026 revenue of ~$22.7M (flat YoY), suspended its full-year 2026 revenue guidance of…
PRESS-RELEASE — Impact 7/10
Oct 15, 2026 Earnings
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
IRVINE, CA – October 15, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the
Aug 13, 2026 Insider
MVM Partners, LLC bought 2,202,643 shares
Director @ $0.4540 ($1000.0K)
Jul 2, 2026 Press
mdxhealth received a Nasdaq deficiency notice for failing to maintain the minimum $1.00 bid price over 30 consecutive…
Impact 7/10
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — DOUBLED
509,674 shares ($209.3K)
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — TRIM
228,510 shares ($93.8K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

11 filings · 2 press releases · 0 bullish · 7 bearish · 1 mixed · 3 neutral
All MDXH filing & press-release reports (13)